Distribution of spoligotyping defined genotypic lineages among drug-resistant Mycobacterium tuberculosis complex clinical isolates in Ankara, Turkey

• Published in: PloS one 2012-01, Vol.7 (1), p.e30331-e30331
• Main Authors: Kisa, Ozgul, Tarhan, Gulnur, Gunal, Selami, Albay, Ali, Durmaz, Riza, Saribas, Zeynep, Zozio, Thierry, Alp, Alpaslan, Ceyhan, Ismail, Tombak, Ahmet, Rastogi, Nalin
• Format: Article
• Language: English
• Subjects: Adult; Aged; Bacterial Typing Techniques - methods; Bacteriology; Biology; Clinical isolates; Cluster Analysis; Clustering; Deoxyribonucleic acid; DNA; DNA fingerprints; DNA Transposable Elements - genetics; DNA, Bacterial - genetics; Drug resistance; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug therapy; Drugs; Epidemiology; Ethambutol; Gene Frequency; Genetic diversity; Genotype; Genotyping Techniques - methods; Humans; Hygiene; Isoniazid; Laboratories; Life Sciences; Medicine; Methods; Microbial drug resistance; Microbial Sensitivity Tests; Microbiology and Parasitology; Middle Aged; Multidrug resistance; Mycobacterium tuberculosis; Mycobacterium tuberculosis - classification; Mycobacterium tuberculosis - genetics; Mycobacterium tuberculosis - isolation & purification; Patients; Phylogeny; Polymorphism; Polymorphism, Restriction Fragment Length; Population genetics; Restriction fragment length polymorphism; Rifampin; Spoligotyping; Streptomycin; Supranationalism; Trends; Tuberculosis; Tuberculosis, Multidrug-Resistant - microbiology; Turkey; University faculty; Young Adult
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0030331

Investigation of genetic heterogeneity and spoligotype-defined lineages of drug-resistant Mycobacterium tuberculosis clinical isolates collected during a three-year period in two university hospitals and National Tuberculosis Reference and Research Laboratory in Ankara, Turkey. A total of 95 drug-resistant M. tuberculosis isolates collected from three different centers were included in this study. Susceptibility testing of the isolates to four major antituberculous drugs was performed using proportion method on Löwenstein-Jensen medium and BACTEC 460-TB system. All clinical isolates were typed by using spoligotyping and IS6110-restriction fragment length polymorphism (RFLP) methods. Seventy-three of the 95 (76.8%) drug resistant M. tuberculosis isolates were isoniazid-resistant, 45 (47.4%) were rifampicin-resistant, 32 (33.7%) were streptomycin-resistant and 31 (32.6%) were ethambutol-resistant. The proportion of multidrug-resistant isolates (MDR) was 42.1%. By using spoligotyping, 35 distinct patterns were observed; 75 clinical isolates were grouped in 15 clusters (clustering rate of 79%) and 20 isolates displayed unique patterns. Five of these 20 unique patterns corresponded to orphan patterns in the SITVIT2 database, while 4 shared types containing 8 isolates were newly created. The most prevalent M. tuberculosis lineages were: Haarlem (23/95, 24.2%), ill-defined T superfamily (22/95, 23.2%), the Turkey family (19/95, 20%; previously designated as LAM7-TUR), Beijing (6/95, 6.3%), and Latin-America & Mediterranean (LAM, 5/95 or 5.3%), followed by Manu (3/95, 3.2%) and S (1/95, 1%) lineages. Four of the six Beijing family isolates (66.7%) were MDR. A combination of IS6110-RFLP and spoligotyping reduced the clustering rate from 79% to 11.5% among the drug resistant isolates. The results obtained showed that ill-defined T, Haarlem, the Turkey family (previously designated as LAM7-TUR family with high phylogeographical specifity for Turkey), Beijing and LAM were predominant lineages observed in almost 80% of the drug-Resistant M. tuberculosis complex clinical isolates in Ankara, Turkey.